BSX

BSX

USD

Boston Scientific Corporation Common Stock

$98.840-0.140 (-0.141%)

Real-time Price

Healthcare
Medical devices
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$98.980

High

$99.310

Low

$98.250

Volume

4.81M

Company Fundamentals

Market Cap

146.5B

Industry

Medical devices

Country

United States

Trading Stats

Avg Volume

8.69M

Exchange

NYQ

Currency

USD

52-Week Range

Low $84.13Current $98.840High $109.5

Related News

Analyst Upgrades

Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $130

Truist Securities analyst Richard Newitter maintains Boston Scientific with a Buy and raises the price target from $129 to $130.

View more
Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $130
Analyst Upgrades

Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $125

Wells Fargo analyst Larry Biegelsen maintains Boston Scientific with a Overweight and raises the price target from $124 to $125.

View more
Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $125
Analyst Upgrades

Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $130

Morgan Stanley analyst Patrick Wood maintains Boston Scientific with a Overweight and raises the price target from $125 to $130.

View more
Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $130
Analyst Upgrades

BTIG Reiterates Buy on Boston Scientific, Maintains $132 Price Target

BTIG analyst Marie Thibault reiterates Boston Scientific with a Buy and maintains $132 price target.

View more
BTIG Reiterates Buy on Boston Scientific, Maintains $132 Price Target
Analyst Upgrades

Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says

Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results and raised guidance.

View more
Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says
PR Newswire

Boston Scientific announces results for third quarter 2025

Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported...

Analyst Upgrades

Evercore ISI Group Maintains Outperform on Boston Scientific, Lowers Price Target to $110

Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific with a Outperform and lowers the price target from $115 to $110.